Effect of Short Term Growth Hormone Releasing Hormone in Healthy Men
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to examine the short-term effects of Growth Hormone Releasing
Hormone (GHRH, tesamorelin) administration in healthy men. We hypothesize that GHRH will
increase GH pulse height and will not affect insulin sensitivity.
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)